Prolonged release oxycodoneanaloxone for treatment of severe restless legs syndrome after failure of...
Prolonged release oxycodoneanaloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension
About this item
Full title
Author / Creator
Journal title
Language
English
Formats
More information
Scope and Contents
Contents
Background Opioids are a potential new treatment for severe restless legs syndrome. We investigated the efficacy and safety of a fixed-dose combination of prolonged release oxycodonenaloxone for patients with severe restless legs syndrome inadequately controlled by previous, mainly dopaminergic, treatment. Methods This multicentre study consisted o...
Alternative Titles
Full title
Prolonged release oxycodoneanaloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1500769400
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1500769400
Other Identifiers
ISSN
1474-4422
DOI
10.1016/S1474-4422(13)70239-4
